Richard Cross compensation by year
Alignment Healthcare Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $386,539 |
| Bonus | $0 |
| Stock awards | $2,107,504 |
| Option awards | $149,999 |
| Non-equity incentive | $225,821 |
| All other | $12,620 |
| Total | $2,882,483 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Alignment Healthcare, Inc. DEF 14A filed April 26, 2023, accession 0000950170-23-014906, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Alignment Healthcare, Inc. filed document, accession 0000950170-23-014906. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 102,759 | $1,208,446 | — |
| RSU | 49,669 | $584,107 | — |
| RSU | 44,910 | $528,142 | — |
| RSU | 44,460 | $522,850 | — |
| RSU | 14,625 | $171,990 | — |
| Option | 36,496 | — | $9.06 |
| Option | 184,167 | — | $18.00 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Alignment Healthcare, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments Alignment Healthcare discloses, by trigger · FY2022| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $600,000 | $0 | $14,737 | $814,737 |
| Involuntary for cause | $0 | $0 | $0 | $0 |
| Change in control, no termination | $0 | $1,050,991 | $0 | $1,050,991 |
| Change in control and involuntary termination | $600,000 | $3,114,074 | $14,737 | $3,928,811 |
| Death | $0 | $0 | $0 | $0 |
| Resignation for good reason, no change in control | $600,000 | $0 | $14,737 | $814,737 |
| Non renewal | $0 | $0 | $0 | $0 |
| Voluntary resignation | $0 | $0 | $0 | $0 |
| Disability | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in Alignment Healthcare, Inc.'s FY2022 proxy. Estimates as the company printed them; a dash means it printed no figure.
Alignment Healthcare’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| John Kao | Chief Executive Officer | $34,070,592 |
| Dawn Maroney | President, Markets | $10,580,760 |
| Dinesh Kumar | Chief Medical and Operating Officer | $8,099,543 |
| Thomas Freeman | Chief Financial Officer | $7,747,097 |
| Richard Cross · this page | General Counsel and Corporate Secretary | $2,882,483 |
The full Alignment Healthcare compensation record
free company briefThis page is one person within Alignment Healthcare's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Alignment Healthcare proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Alignment Healthcare's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.